Adenomyosis

Differentiating adenomyosis from uterine fibroids, particularly leiomyomas, can be challenging clinically. Imaging plays a crucial role. On ultrasound, adenomyosis may present as a diffusely enlarged uterus with heterogeneous myometrial echotexture, sometimes exhibiting small cystic spaces. Fibroids, conversely, typically appear as well-circumscribed, hypoechoic masses within the myometrium. MRI provides superior resolution, depicting adenomyosis as a thickened junctional zone (greater than 12mm), often with linear striations or diffuse hyperintensity within the myometrium. Fibroids on MRI exhibit low signal intensity on T1-weighted and T2-weighted images, distinct from the surrounding myometrium. However, overlapping features can occur, particularly with small fibroids or diffuse adenomyosis. Consider implementing a combined approach incorporating clinical presentation, patient history (e.g., dysmenorrhea, menorrhagia), and multiple imaging modalities for a definitive diagnosis. Explore how utilizing standardized reporting systems like the MORPH classification can enhance diagnostic accuracy and improve communication among clinicians. Learn more about the current guidelines on imaging modalities for uterine pathology.

Managing adenomyosis-related dysmenorrhea and menorrhagia in premenopausal patients desiring future fertility requires a tailored approach. Hormonal therapies, such as combined oral contraceptives, progestins (e.g., levonorgestrel-releasing intrauterine system), and gonadotropin-releasing hormone agonists, can effectively reduce symptoms. For localized disease, uterine artery embolization may offer an alternative, though its impact on future fertility warrants careful consideration and discussion with the patient. Conservative surgical interventions, including adenomyomectomy, aim to remove adenomyotic tissue while preserving the uterus. This approach can be technically challenging and requires surgical expertise. Non-steroidal anti-inflammatory drugs (NSAIDs) offer symptomatic relief for dysmenorrhea. Consider implementing a stepped-care approach, initiating therapy with less invasive options like hormonal management and NSAIDs, and reserving more invasive procedures for cases unresponsive to conservative measures. Explore how a multidisciplinary approach involving gynecologists, radiologists, and fertility specialists can optimize outcomes for patients wishing to preserve fertility.

The pathogenesis of adenomyosis remains incompletely understood, but recent research suggests a multifactorial etiology. Emerging evidence points to the role of endometrial stem/progenitor cells in the development of adenomyosis, potentially migrating into the myometrium through disruptions in the endometrial-myometrial interface. Inflammation and altered immune responses within the uterine microenvironment are also implicated, with studies highlighting the involvement of cytokines and inflammatory mediators in the pathogenesis. Genetic predisposition likely plays a role, with familial clustering observed and investigations into specific genetic polymorphisms underway. Furthermore, the role of estrogen and progesterone in promoting the growth and survival of ectopic endometrial tissue within the myometrium continues to be an area of active investigation. Explore the latest publications on the role of epigenetic modifications and their potential contribution to adenomyosis development. Learn more about ongoing research exploring novel therapeutic targets based on these evolving insights into the pathogenesis of adenomyosis.